| 臺大學術典藏 |
2021-01-28T01:06:45Z |
A phase II trial of weekly paclitaxel and high-dose 5-fluorouracil plus leucovorin in patients with chemotherapy-pretreated metastatic breast cancer
|
Lin C.-C.;Cheng A.-L.;Hsu C.-H.;Lu Y.-S.;Hsu C.;Kun-Huei Yeh;Wu C.-Y.;Huang C.-S.;Yang C.-H.; Lin C.-C.; Cheng A.-L.; Hsu C.-H.; Lu Y.-S.; Hsu C.; KUN-HUEI YEH; Wu C.-Y.; Huang C.-S.; Yang C.-H. |
| 臺大學術典藏 |
2021-01-28T01:06:45Z |
Differential response to H. pylori eradication therapy of co-existing diffuse large B-cell lymphoma and MALT lymphoma of stomach - Significance of tumour cell clonality and BCL10 expression
|
Kuo S.-H.;Chen L.-T.;Wu M.-S.;Kuo K.-T.;Kun-Huei Yeh;Doong S.-L.;Yeh P.-Y.;Hsu H.-C.;Tzeng Y.-S.;Lin C.-W.;Lin J.-T.;Cheng A.L.; Kuo S.-H.; Chen L.-T.; Wu M.-S.; Kuo K.-T.; KUN-HUEI YEH; Doong S.-L.; Yeh P.-Y.; Hsu H.-C.; Tzeng Y.-S.; Lin C.-W.; Lin J.-T.; Cheng A.L. |
| 臺大學術典藏 |
2021-01-28T01:06:46Z |
An open, multi-centre, phase II clinical trial to evaluate the efficacy and safety of paclitaxel, UFT, and leucovorin in patients with advanced gastric cancer
|
Chao Y.;Li C.P.;Chao T.Y.;Su W.C.;Hsieh R.K.;Wu M.F.;Kun-Huei Yeh;Kao W.Y.;Chen L.T.;Cheng A.L.; Chao Y.; Li C.P.; Chao T.Y.; Su W.C.; Hsieh R.K.; Wu M.F.; KUN-HUEI YEH; Kao W.Y.; Chen L.T.; Cheng A.L. |
| 臺大學術典藏 |
2021-01-28T01:06:46Z |
Concurrent chemoradiotherapy with twice weekly paclitaxel and cisplatin followed by esophagectomy for locally advanced esophageal cancer
|
Lin C.-C.;Hsu C.-H.;Cheng J.C.;Wang H.-P.;Lee J.-M.;Kun-Huei Yeh;Yang C.-H.;Lin J.-T.;Cheng A.-L.;Lee Y.-C.; Lin C.-C.; Hsu C.-H.; Cheng J.C.; Wang H.-P.; Lee J.-M.; KUN-HUEI YEH; Yang C.-H.; Lin J.-T.; Cheng A.-L.; Lee Y.-C. |
| 臺大學術典藏 |
2021-01-28T01:06:46Z |
Disseminated Mycobacterium kansasii infection in an HIV-negative patient presenting with mimicking multiple bone metastases
|
Tsai C.-W.;Wang J.-T.;Tsai C.-C.;Kun-Huei Yeh; Tsai C.-W.; Wang J.-T.; Tsai C.-C.; KUN-HUEI YEH |
| 臺大學術典藏 |
2021-01-28T01:06:47Z |
A pathway for tumor necrosis factor-α-induced Bcl10 nuclear translocation: Bcl10 is up-regulated by NF-κB and phosphorylated by Akt1 and then complexes with Bcl3 to enter the nucleus
|
Pei Y.Y.;Kuo S.-H.;Kun-Huei Yeh;Chuang S.-E.;Hsu C.-H.;Wen C.C.;Lin H.-I.;Gao M.;Cheng A.-L.; Pei Y.Y.; Kuo S.-H.; KUN-HUEI YEH; Chuang S.-E.; Hsu C.-H.; Wen C.C.; Lin H.-I.; Gao M.; Cheng A.-L. |
| 臺大學術典藏 |
2021-01-28T01:06:47Z |
Somatic mutations in epidermal growth factor receptor underlying complete responsiveness to gefitinib in a Taiwanese female patient with metastatic adenocarcinoma of lung
|
Kun-Huei Yeh;Yeh S.-H.;Wan J.-P.;Shen Y.-C.;Cheng A.-L.; KUN-HUEI YEH; Yeh S.-H.; Wan J.-P.; Shen Y.-C.; Cheng A.-L. |
| 臺大學術典藏 |
2021-01-28T01:06:47Z |
Effects of glucocorticoids on the growth and chemosensitivity of carcinoma cells are heterogeneous and require high concentration of functional glucocorticoid receptors
|
Lu Y.-S.;Lien H.-C.;Yeh P.-Y.;Kun-Huei Yeh;Kuo M.-L.;Kuo S.-H.;Cheng A.-L.; Lu Y.-S.; Lien H.-C.; Yeh P.-Y.; KUN-HUEI YEH; Kuo M.-L.; Kuo S.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2021-01-28T01:06:48Z |
Phase II study of weekly paclitaxel and 24-hour infusion of high-dose 5-fluorouracil and leucovorin in the treatment of recurrent or metastatic gastric cancer
|
Kun-Huei Yeh;Lu Y.-S.;Hsu C.-H.;Lin J.-F.;Hsu C.;Kuo S.-H.;Li Jr. S.;Cheng A.-L.; KUN-HUEI YEH; Lu Y.-S.; Hsu C.-H.; Lin J.-F.; Hsu C.; Kuo S.-H.; Li Jr. S.; Cheng A.-L. |
| 臺大學術典藏 |
2021-01-28T01:06:48Z |
Survival outcome of inoperable non-small cell lung cancer patients receiving conventional dose epirubicin and paclitaxel as first-line treatment
|
Yang C.-H.;Chen M.-C.;Cheng A.-L.;Hsu C.-H.;Kun-Huei Yeh;Yu Y.-C.;Whang-Peng J.;Yang P.-C.; Yang C.-H.; Chen M.-C.; Cheng A.-L.; Hsu C.-H.; KUN-HUEI YEH; Yu Y.-C.; Whang-Peng J.; Yang P.-C. |
| 臺大學術典藏 |
2021-01-28T01:06:48Z |
Nuclear expression of BCL10 or nuclear factor kappa B helps predict Helicobacter pylori-independent status of low-grade gastric mucosa-associated lymphoid tissue lymphomas with or without t(11;18)(q21;q21 )
|
Kun-Huei Yeh;Kuo S.-H.;Chen L.-T.;Mao T.-L.;Doong S.-L.;Wu M.-S.;Hsu H.-C.;Tzeng Y.-S.;Chen C.-L.;Lin J.-T.;Cheng A.-L.; KUN-HUEI YEH; Kuo S.-H.; Chen L.-T.; Mao T.-L.; Doong S.-L.; Wu M.-S.; Hsu H.-C.; Tzeng Y.-S.; Chen C.-L.; Lin J.-T.; Cheng A.-L. |
| 臺大學術典藏 |
2021-01-28T01:06:49Z |
Expression of CD86 and increased inflitration of NK cells are associated with Helicobacter pylori-dependent state of early stage high-grade gastric MALT lymphoma
|
Kuo S.-H.;Chen L.-T.;Chen C.-L.;Doong S.-L.;Kun-Huei Yeh;Wu M.-S.;Mao T.-L.;Hsu H.-C.;Wang H.-P.;Lin J.-T.;Cheng A.-L.; Kuo S.-H.; Chen L.-T.; Chen C.-L.; Doong S.-L.; KUN-HUEI YEH; Wu M.-S.; Mao T.-L.; Hsu H.-C.; Wang H.-P.; Lin J.-T.; Cheng A.-L. |
| 臺大學術典藏 |
2021-01-28T01:06:49Z |
Nuclear expression of BCL10 or nuclear factor kappa B predicts Helicobacter pylori-independent status of early-stage, high-grade gastric mucosa-associated lymphoid tissue lymphomas
|
Kuo S.-H.;Chen L.-T.;Kun-Huei Yeh;Wu M.-S.;Hsu H.-C.;Yeh P.-Y.;Mao T.-L.;Chen C.-L.;Doong S.-L.;Lin J.-T.;Cheng A.-L.; Kuo S.-H.; Chen L.-T.; KUN-HUEI YEH; Wu M.-S.; Hsu H.-C.; Yeh P.-Y.; Mao T.-L.; Chen C.-L.; Doong S.-L.; Lin J.-T.; Cheng A.-L. |
| 臺大學術典藏 |
2021-01-28T01:06:49Z |
Phase II study of weekly vinorelbine and 24-h infusion of high-dose 5-fluorouracil plus leucovorin as first-line treatment of advanced breast cancer
|
Kun-Huei Yeh;Lu Y.S.;Hsu C.H.;Lin J.F.;Chao H.J.;Huang T.C.;Chung C.Y.;Chang C.S.;Yang C.H.;Cheng A.L.; KUN-HUEI YEH; Lu Y.S.; Hsu C.H.; Lin J.F.; Chao H.J.; Huang T.C.; Chung C.Y.; Chang C.S.; Yang C.H.; Cheng A.L. |
| 臺大學術典藏 |
2021-01-28T01:06:50Z |
Suppression of MEK/ERK signaling pathway enhances cisplatin-induced NF-κB activation by protein phosphatase 4-mediated NF-κB p 65 Thr dephosphorylation
|
Yeh P.Y.;Kun-Huei Yeh;Chuang S.-E.;Song Y.C.;Cheng A.-L.; Yeh P.Y.; KUN-HUEI YEH; Chuang S.-E.; Song Y.C.; Cheng A.-L. |
| 臺大學術典藏 |
2021-01-28T01:06:50Z |
Phase II study of combination doxorubicin, interferon-α, and high-dose tamoxifen treatment for advanced hepatocellular carcinoma
|
Lu Y.-S.;Hsu C.;Li C.-C.;Kuo S.-H.;Kun-Huei Yeh;Yang C.-H.;Hsu C.-H.;Wu C.-Y.;Cheng A.-L.; Lu Y.-S.; Hsu C.; Li C.-C.; Kuo S.-H.; KUN-HUEI YEH; Yang C.-H.; Hsu C.-H.; Wu C.-Y.; Cheng A.-L. |
| 臺大學術典藏 |
2021-01-28T01:06:50Z |
Phase II study of weekly oxaliplatin and 24-h infusion of high-dose 5-fluorouracil and folinic acid in the treatment of advanced gastric cancer
|
Chao Y.;Kun-Huei Yeh;Chang C.J.;Chen L.T.;Chao T.Y.;Wu M.F.;Chang C.S.;Chang J.Y.;Chung C.Y.;Kao W.Y.;Hsieh R.K.;Cheng A.L.; Chao Y.; KUN-HUEI YEH; Chang C.J.; Chen L.T.; Chao T.Y.; Wu M.F.; Chang C.S.; Chang J.Y.; Chung C.Y.; Kao W.Y.; Hsieh R.K.; Cheng A.L. |
| 臺大學術典藏 |
2021-01-28T01:06:50Z |
Weekly gemcitabine plus 24-h infusion of high-dose 5-fluorouracil/ leucovorin for locally advanced or metastatic carcinoma of the biliary tract
|
Hsu C.;Shen Y.-C.;Yang C.-H.;Kun-Huei Yeh;Lu Y.-S.;Hsu C.-H.;Liu H.-T.;Li C.-C.;Chen J.-S.;Wu C.-Y.;Cheng A.-L.; Hsu C.; Shen Y.-C.; Yang C.-H.; KUN-HUEI YEH; Lu Y.-S.; Hsu C.-H.; Liu H.-T.; Li C.-C.; Chen J.-S.; Wu C.-Y.; Cheng A.-L. |
| 臺大學術典藏 |
2021-01-28T01:06:51Z |
Recent advances in therapy for gastric cancer
|
Kun-Huei Yeh;Cheng A.-L.; KUN-HUEI YEH; Cheng A.-L. |
| 臺大學術典藏 |
2021-01-28T01:06:51Z |
High-dose Tamoxifen Modulates Drug Resistance to Doxorubicin, Dacarbazine and Ifosfamide in Metastatic Uterine Leiomyosarcoma
|
Kun-Huei Yeh;Lu Y.-S.;Hsiao C.-H.;Cheng A.-L.; KUN-HUEI YEH; Lu Y.-S.; Hsiao C.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2021-01-28T01:06:51Z |
Involvement of nuclear transcription factor-κB in low-dose doxorubicin-induced drug resistance of cervical carcinoma cells
|
Yeh P.Y.;Chuang S.-E.;Kun-Huei Yeh;Song Y.C.;Cheng A.-L.; Yeh P.Y.; Chuang S.-E.; KUN-HUEI YEH; Song Y.C.; Cheng A.-L. |
| 臺大學術典藏 |
2021-01-28T01:06:51Z |
Phosphorylation of p53 on Thr55 by ERK2 is necessary for doxorubicin-induced p53 activation and cell death
|
Yeh P.Y.;Chuang S.-E.;Kun-Huei Yeh;Song Y.C.;Chang L.L.-Y.;Cheng A.-L.; Yeh P.Y.; Chuang S.-E.; KUN-HUEI YEH; Song Y.C.; Chang L.L.-Y.; Cheng A.-L. |
| 臺大學術典藏 |
2021-01-28T01:06:51Z |
Down-regulation of thymidylate synthase expression and its steady-state mRNA by oxaliplatin in colon cancer cells
|
Kun-Huei Yeh;Cheng A.-L.;Wan J.-P.;Lin C.-S.;Liu C.-C.; KUN-HUEI YEH; Cheng A.-L.; Wan J.-P.; Lin C.-S.; Liu C.-C. |
| 臺大學術典藏 |
2021-01-28T01:06:52Z |
A phase II study of weekly methotrexate, cisplatin, and 24-hour infusion of high-dose 5-fluorouracil and leucovorin (MP-HDFL) in patients with metastatic and recurrent esophageal cancer-improving toxicity profile by infusional schedule and double biochemical modulation of 5-fluorouracil
|
Hsu C.-H.;Cheng A.-L.;Hsu C.;Yang C.-H.;Lu Y.-S.;Lin C.-C.;Bu C.-F.;Kun-Huei Yeh; Hsu C.-H.; Cheng A.-L.; Hsu C.; Yang C.-H.; Lu Y.-S.; Lin C.-C.; Bu C.-F.; KUN-HUEI YEH |
| 臺大學術典藏 |
2021-01-28T01:06:52Z |
Increase of the resistance of human cervical carcinoma cells to cisplatin by inhibition of the MEK to ERK signaling pathway partly via enhancement of anticancer drug-induced NFκB activation
|
Yeh P.Y.;Chuang S.-E.;Kun-Huei Yeh;Song Y.C.;Ea C.-K.;Cheng A.-L.; Yeh P.Y.; Chuang S.-E.; KUN-HUEI YEH; Song Y.C.; Ea C.-K.; Cheng A.-L. |
